Hematopoietic Progenitor Cell Mobilization with “Just-in-Time” Plerixafor Approach is a Cost Effective Alternative to Routine Plerixafor Use

Hematopoietic progenitor cell (HPC) mobilization with granulocyte-colony stimulating factor (G-CSF) and plerixafor results in superior CD34+ cell yield, when compared to mobilization with G-CSF alone in patients with myeloma and lymphoma. However, plerixafor-based approaches are associated with high...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cytotherapy
Autores principales: Veltri, Lauren, Cumpston, Aaron, Shillingburg, Alexandra, Wen, Sijin, Luo, Jin, Leadmon, Sonia, Watkins, Kathy, Craig, Michael, Hamadani, Mehdi, Kanate, Abraham S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4700501/
https://ncbi.nlm.nih.gov/pubmed/26475754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2015.09.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares